Objectives
After participating in this educational activity, attendees should be able to:
1|Describe factors associated with HS treatment satisfaction and dissatisfaction to meaningfully address care gaps
2|Discuss the vital role for surgery in treating recurrent or persistent HS nodules and tunnels
3|Discuss an approach to managing HS pain
4|Develop effective management strategies to address drainage, odor, and flares
Presenter
Sarah Whitley, MD, PhD
Assistant Professor of Dermatology
UMass Chan Medical School
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Sarah Whitley, MD, PhD | Speaker | AbbVie, Consultant and investigator, 2022-present Novartis, Investigator, 2024-present Incyte, Investigator and consultant, 2025-present UCB, consultant, 2025-present Citryll, investigator, 2025-present Regeneron, consultant, 2024 | Yes |
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 American Board of Surgery MOC
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward